Lundbeck
HLUN-B.CO
#2857
Rank
NZ$10.05 B
Marketcap
NZ$10.14
Share price
-1.99%
Change (1 day)
5.83%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): NZ$1.03

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.02. an increase over its 2024 EPS that were of NZ$0.74.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ$0.8514.5%
2024NZ$0.7429.29%
2023NZ$0.5723.09%
2022NZ$0.4637.26%
2021NZ$0.34-84.61%
2020NZ$2.20-24.61%
2019NZ$2.92-42.06%
2018NZ$5.0440.7%
2017NZ$3.58146.26%
2016NZ$1.45-120.48%
2015NZ-$7.103231.32%
2014NZ-$0.21-115.78%
2013NZ$1.35-23.36%
2012NZ$1.76-48.01%
2011NZ$3.39-9.68%
2010NZ$3.7513.72%
2009NZ$3.3024.32%
2008NZ$2.65-6.05%
2007NZ$2.8281.77%
2006NZ$1.55-16.76%
2005NZ$1.87-17.58%
2004NZ$2.27